<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Cardiovascular disease is a major cause of mortality among oncologic patients. As cancer therapies continue to evolve and advance, cancer survival rates have been increasing and so has the burden of cardiovascular disease within this population. For this reason, cardio-oncology plays an important role in promoting multidisciplinary care with the primary care provider, oncology, and cardiology. In this review, we discuss the roles of different providers, strategies to monitor patients receiving cardiotoxic therapies, and summarize cancer therapy class-specific toxicities. Continued collaboration among providers and ongoing research related to cardiotoxic cancer therapies will enable patients to receive maximal, evidence-based, comprehensive care.</p>
</abstract>

Cardiovascular disease is a major cause of mortality among oncologic patients. As cancer therapies continue to evolve and advance, cancer survival rates have been increasing and so has the burden of cardiovascular disease within this population. For this reason, cardio-oncology plays an important role in promoting multidisciplinary care with the primary care provider, oncology, and cardiology. In this review, we discuss the roles of different providers, strategies to monitor patients receiving cardiotoxic therapies, and summarize cancer therapy class-specific toxicities. Continued collaboration among providers and ongoing research related to cardiotoxic cancer therapies will enable patients to receive maximal, evidence-based, comprehensive care.

Cardio-Oncology for the Primary Care Provider

Romanian Journal of Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Cardio-Oncology for the Primary Care Provider"}

Cardiovascular disease is a major cause of mortality among oncologic patients. As cancer therapies continue to evolve and advance, cancer survival rates have...

Cardio-Oncology for the Primary Care Provider

Online veröffentlicht: 30. Mai 2023

Seitenbereich: 127 - 134

Eingereicht: 03. Apr. 2023

DOI: https://doi.org/10.2478/rjim-2023-0012

Schlüsselwörter
primary care, oncology, cardiovascular diseases, cardiotoxicity, chemotherapy

© 2023 Nikita Jhawar et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Cardio-Oncology for the Primary Care Provider

Online veröffentlicht: 30. Mai 2023

Seitenbereich: 127 - 134

Eingereicht: 03. Apr. 2023

DOI: https://doi.org/10.2478/rjim-2023-0012

Schlüsselwörterprimary care, oncology, cardiovascular diseases, cardiotoxicity, chemotherapy

© 2023 Nikita Jhawar et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
primary care, oncology, cardiovascular diseases, cardiotoxicity, chemotherapy